| F NK 3/21 |
| Date/Time | / |
| Chg. / Chg.(%) | - / |
| Bid | - |
| Ask | - |
| Open | 21,650.00 |
| Previous Close | - |
| High | 21,650.00 |
| Low | 21,650.00 |
| Volume [USD] | - |
| Volume [Units] | |
| Price fixings | |
| ISIN | |
| Security | NK |
| Exchange | CME |
| Type | Futures Contract |
News
- SHAREHOLDER ALERT: Barr Law Group Investigating NK, IQDNX, JELD, and MDXG; Shareholders are Encouraged to Contact the Firm
09:00 - GlobeNewswire - INmune Bio, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results and Provide a Corporate Update on Thursday, March 4
02/25/2021 / 15:00 - GlobeNewswire - Celsion Corporation Provides Clinical Update on Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer Including Encouraging Interim Resection Scores
02/25/2021 / 14:45 - GlobeNewswire - Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update
02/25/2021 / 13:00 - GlobeNewswire - Fate Therapeutics Reports Fourth Quarter 2020 Financial Results and Highlights Operational Progress
02/24/2021 / 22:01 - GlobeNewswire
Real-time